tranexamic acid has been researched along with Erythrophagocytic Lymphohistiocytosis, Familial in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friesecke, S | 1 |
| Stecher, SS | 1 |
| Greinacher, A | 1 |
1 other study available for tranexamic acid and Erythrophagocytic Lymphohistiocytosis, Familial
| Article | Year |
|---|---|
Tranexamic acid for treatment of bleeding in hemophagocytic lymphohistiocytosis.
Topics: Adult; Antifibrinolytic Agents; Female; Fibrinogen; Hemorrhage; Humans; Lymphohistiocytosis, Hemopha | 2015 |